BOSTON— A federal jury has rejected claims by a group of Massachusetts smokers who sued Philip Morris USA to try to force the cigarette maker to pay for lung cancer screenings. Instead they wanted Philip Morris to pay for a medical-monitoring program, including three-dimensional chest scans that can detect signs of early-stage lung cancer.» Read More
The U.S. Food and Drug Administration proposed asserting its authority over new tobacco products on Thursday.
A man may have been allowed to use an electronic cigarette on a flights from Calgary to Toronto.
More than two dozen attorneys general are asking drug chains to pull cigarettes from their shelves. But, Lorillard just got upgraded by Goldman Sachs.
We expected to see some lumps and bumps in the rollout, says George Barrett, Cardinal Health CEO, and Jeffrey Sonnenfeld, Yale School of Management, discussing how Obamacare is prompting change within the health care industry.
Attorneys general is 28 states urged Wal-mart and four other retailers to stop selling tobacco products. They said they should not be sold in health stores.
Lorillard is trading higher after a Goldman upgrade. Fast Money traders Pete Najarian and Josh Brown debate their position on the tobacco company.
Los Angeles is the latest city to restrict the use of e-cigarettes in public places. Miguel Martin, Logic Technology Development president, says the e-cigarette business is currently $2 billion, and discusses how the big players are handling regulations.
Smoke breaks may be costing employers more than they think, with U.K. businesses losing around $14.50 billion a year, according to a new study.
A merger between Reynolds American and Lorillard would have benefits in their domestic market. It could also kick off more deals overseas.
Elaine Coverley, head of equity research at Brewin Dolphin, says companies are taking advantage of the uncertain regulation in the e-cigarette sector by advertising.
Dave Dorman, CVS Caremark chairman of the board, weighs in on why he is not "surprised" by the weak jobs number, and defends his company's decision to stop selling tobacco products to customers at CVS.
Richard Fisher, Federal Reserve Bank of Dallas president, weighs in on the weak jobs number and the likelihood of the Fed interrupting its tapering program. Also Dave Dorman, CVS Caremark chairman of the board, weighs in on the employment picture.
Stacey Widlitz, SW Retail Advisors, looks at who will profit from CVS's decision to stop the sale of tobacco products.
Beginning October 1st, CVS will no longer sell tobacco products in any store. NBC's Tom Costello reports CVS wants to be an extension of your doctor's office.
CNBC's Jim Cramer explains why he thinks CVS' move to end tobacco sales could only work in a fantasy world.
Beginning October 1st, CVS will no longer sell tobacco products in any store. NBC's Tom Costello reports the retailer could no longer reconcile the contradiction of promoting health while selling tobacco products.
CVS Caremark says it will stop selling tobacco products, making it the first major pharmacy retailer to voluntarily do so.
Scott Mushkin, Wolfe Research analyst, explains why the decision not to sell tobacco products is a good move by CVS.
A look at how the decision to pull cigarettes from their shelves will impact CVS stock, with Nik Modi, RBC analyst.
NBC's Tom Costello reports the latest details on the decision from CVS to remove tobacco products from their stores.